These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17302380)

  • 21. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
    Fuster D; Planas R; Gonzalez J; Force L; Cervantes M; Vilaró J; Roget M; García I; Pedrol E; Tor J; Ballesteros AL; Salas A; Sirera G; Videla S; Clotet B; Tural C
    Antivir Ther; 2006; 11(4):473-82. PubMed ID: 16856621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.
    Torriani FJ; Ribeiro RM; Gilbert TL; Schrenk UM; Clauson M; Pacheco DM; Perelson AS
    J Infect Dis; 2003 Nov; 188(10):1498-507. PubMed ID: 14624375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
    Neumann A; Polis M; Rozenberg L; Jackson J; Reitano K; McLaughlin M; Koratich C; Dewar R; Masur H; Haagmans B; Kottilil S
    AIDS; 2007 Sep; 21(14):1855-65. PubMed ID: 17721093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.
    De Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Cariti G; Raiteri R; Di Perri G
    J Antimicrob Chemother; 2006 Feb; 57(2):360-3. PubMed ID: 16396921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
    Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
    Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.
    Kamal SM; El Tawil AA; Nakano T; He Q; Rasenack J; Hakam SA; Saleh WA; Ismail A; Aziz AA; Madwar MA
    Gut; 2005 Jun; 54(6):858-66. PubMed ID: 15888797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
    Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients].
    Martínez-Rebollar M; Mallolas J; Pérez I; González-Cordón A; Loncà M; Torres B; Rojas JF; Monteiro P; Blanco JL; Martínez E; Gatell JM; Laguno M
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):3-8. PubMed ID: 25124489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
    Nattermann J; Vogel M; Berg T; Danta M; Axel B; Mayr C; Bruno R; Tural C; Klausen G; Clotet B; Lutz T; Grünhage F; Rausch M; Nischalke HD; Schewe K; Bienek B; Haerter G; Sauerbruch T; Rockstroh JK; Spengler U;
    Hepatology; 2007 Oct; 46(4):1016-25. PubMed ID: 17668881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?
    Vogel M; Page E; Nelson M; Rockstroh JK
    J HIV Ther; 2009 Mar; 14(1):8-12. PubMed ID: 19731559
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of early pegylated interferon alpha-2b monotherapy for acute hepatitis C in HIV-infected patients.
    De Rosa FG; Mollaretti O; Audagnotto S; De Blasi T; Cariti G; Marucco DM; Bonora S; Perri GD
    Clin Infect Dis; 2009 Jun; 48(11):1636-7. PubMed ID: 19416030
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2b.
    Mukherjee S; Gilroy RK; Schafer DF
    Am J Gastroenterol; 2002 Aug; 97(8):2152-3. PubMed ID: 12190203
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute HIV seroconversion in a patient receiving pegylated interferon for treatment of hepatitis C.
    Maser E; Dieterich DT
    AIDS Read; 2003 Jun; 13(6):279-80, 287. PubMed ID: 12846173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cure of acute hepatitis C in HIV co-infection?
    Ristig MB; Tebas P; Gandy I; Qaqish R; Aberg JA
    J Clin Gastroenterol; 2004 Mar; 38(3):303. PubMed ID: 15128087
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.
    Wiegand J; Deterding K; Cornberg M; Wedemeyer H
    J Antimicrob Chemother; 2008 Nov; 62(5):860-5. PubMed ID: 18776191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.
    Kaplan-Lewis E; Fierer DS
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):317-25. PubMed ID: 26152661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life with pegylated interferon therapy for hepatitis C.
    Brown RS
    Hepatology; 2002 Sep; 36(3):767-8; author reply 768. PubMed ID: 12198677
    [No Abstract]   [Full Text] [Related]  

  • 40. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Early treatment of sexually transmitted hepatitis C.
    TreatmentUpdate; 2006; 18(2):2-3. PubMed ID: 17228453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.